California Cannabis Sales Dip for Third Straight Year: What's Driving the Decline?

California was supposed to be the promised land of legal cannabis. Home to the world's largest regulated marijuana market, the state that pioneered medical cannabis in 1996 and launched adult-use sales in 2018 was expected to set the global standard for what a mature, successful legal market looks like.

Instead, 2026 marks the third consecutive year that the Golden State's licensed cannabis industry has posted declining revenues — and the industry is grappling with a stubborn set of structural problems that no amount of product innovation or marketing can easily fix.

The Q1 2026 Numbers

Licensed California cannabis retailers reported $956.7 million in sales during the first quarter of 2026, according to the California Department of Tax and Fee Administration. That's down from $976.5 million in Q1 2025, and well below the $1.07 billion posted in Q1 2024.

For context, California licensed retailers recorded $3.9 billion in total cannabis sales for all of 2025 — itself a step down from $4.2 billion in 2024 and part of a multi-year retreat from the market's 2021 peak.

The state did collect approximately $248 million in cannabis tax revenue in the first quarter — including $143.6 million from excise taxes and $104.3 million from sales taxes — which underscores that while revenue is declining, California's cannabis economy remains enormous in absolute terms. But the direction of travel is deeply concerning for operators, investors, and the tens of thousands of people employed in the state's legal market.

The Illicit Market: Public Enemy Number One

Ask any California cannabis operator about the single biggest drag on legal market growth, and the answer is almost always the same: the illicit market.

California's illegal cannabis industry never disappeared after legalization — it adapted. Unlicensed dispensaries, delivery services, and outdoor grows operate throughout the state, often selling products at prices 30–50% below licensed retailer levels. A gram that costs $15 at a licensed dispensary (after excise tax, sales tax, and the retailer's compliance costs) might cost $8 or $9 from an unlicensed source.

For price-sensitive consumers — and in California's challenging economic climate, that's a large and growing share of buyers — the math is difficult to ignore. State regulators reported record seizures of illegal cannabis in 2025, pointing to continued and robust demand for products sold outside licensed channels.

The problem is structural. California's cannabis taxes are among the highest in the nation, and the cost of full legal compliance — licensing fees, track-and-trace systems, required testing, local permits — adds significant overhead to licensed operators that their illicit competitors simply don't bear.

Price Compression in the Legal Market

Even within the legal market, operators are facing severe price compression. The average price per gram of cannabis in California has declined steadily since 2018, a reflection of oversupply relative to licensed demand.

In Q1 2026, vape products were the biggest sellers at $350.8 million — continuing a nearly yearlong trend of outselling flower. Flower sales came in at $312.8 million. But across categories, the pattern is consistent: more units sold, but at lower per-unit revenue, squeezing margins for producers, processors, and retailers alike.

This dynamic is part of a national trend. According to industry data, the number of active cannabis business licenses in the United States fell to 37,555 in the most recent quarter, with the total number of active licenses nationwide declining 13% over the past two years. The industry is consolidating under pressure.

The Tax and Regulatory Burden

California's cannabis tax structure has long been criticized as a significant barrier to legal market competitiveness. The state charges both an excise tax (currently 15%) and standard sales tax on cannabis purchases, while local jurisdictions can add their own taxes on top — meaning consumers in some California cities effectively pay 30–35% in combined taxes on cannabis purchases.

Various tax relief proposals have moved through the California legislature, and lawmakers have made incremental adjustments, but no comprehensive reform has been enacted. Industry advocates argue that without meaningful tax reduction, the legal market will continue to lose ground to the untaxed illicit alternatives.

Federal Rescheduling: A Potential Lifeline

One development that could materially improve the California cannabis industry's outlook is federal action. The U.S. Department of Justice's April 2026 order placing state-licensed medical cannabis products in Schedule III — and the DEA's upcoming June 29 hearing on broader rescheduling — raises the possibility of meaningful changes to the federal tax burden on cannabis businesses.

Section 280E of the federal tax code currently prohibits cannabis companies from deducting ordinary business expenses because marijuana remains a Schedule I controlled substance. This results in effective federal tax rates for cannabis businesses that can exceed 70% of gross profit. Schedule III reclassification of recreational and medical cannabis would allow businesses to claim standard deductions, dramatically improving profitability across the industry.

For California's licensed operators, relief from 280E would be transformational — potentially the single biggest improvement to their economics since legalization.

The Road Ahead

California's cannabis market is not in terminal decline. At nearly $4 billion in annual licensed sales, it remains the largest cannabis economy in the world. The state's licensed industry continues to generate hundreds of millions in tax revenue, supports over 60,000 jobs, and produces some of the most innovative cannabis products available anywhere.

But the gap between the legal market's potential and its current performance is real, and the forces suppressing it — illicit competition, tax burden, price compression, and over-regulation at the local level — are not going away on their own.

Industry observers suggest that meaningful progress will require action on multiple fronts simultaneously: sustained enforcement against the illicit market, state tax reform, and federal policy changes that improve the financial viability of compliance. Without that multi-pronged approach, California's legal cannabis industry may continue its slow retreat from a peak it may never reclaim.

Key Takeaways

• California licensed cannabis sales reached $956.7 million in Q1 2026, down from $976.5 million a year earlier and part of a three-year declining trend from the 2021 peak.
• The illicit market continues to be the primary competitive threat, with unlicensed sellers offering prices 30–50% below licensed retailers.
• Price compression is squeezing margins even within the legal market, with more units sold but at lower per-unit revenue.
• Active cannabis business licenses in the US have declined 13% over two years, pointing to widespread industry consolidation.
• Federal rescheduling and 280E tax reform could provide the most significant economic relief to California operators if enacted.

Track cannabis market trends, find the best dispensaries in California, and explore strain guides at Budpedia.